Acutus Medical Reports First Quarter 2023 Financial Results
| AFIBDelisted Stock | USD 0.73 0.03 3.95% |
About 61% of Acutus Medical's investor base is looking to short. The analysis of overall sentiment of trading Acutus Medical stock suggests that many investors are alarmed at this time. The current market sentiment, together with Acutus Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Acutus Medical stock news signals to limit their universe of possible portfolio assets.
Acutus |
CARLSBAD, Calif., May 11, 2023 Acutus Medical, Inc. , an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the first quarter of 2023. Recent Highlights Reported revenue of 4.2 million for the first quarter of 2023, a 13 percent increase compared to 3.7 million for the same quarter last year.Continued improvement in financial performance with year-over-year
Read at finance.yahoo.com
 |
Acutus Medical Fundamental Analysis
We analyze Acutus Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acutus Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acutus Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Acutus Medical is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Acutus Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Acutus Medical stock to make a market-neutral strategy. Peer analysis of Acutus Medical could also be used in its relative valuation, which is a method of valuing Acutus Medical by comparing valuation metrics with similar companies.
Peers
Acutus Medical Related Equities
| AIMD | Ainos | 4.44 | ||||
| ATEC | Alphatec Holdings | 1.21 | ||||
| AORT | Artivion | 0.95 | ||||
| ANIK | Anika Therapeutics | 0.62 | ||||
| LNSR | LENSAR | 0.46 | ||||
| OFIX | Orthofix Medical | 0.06 | ||||
| CVRX | CVRx | 0.00 | ||||
| DCTH | Delcath Systems | 0.09 | ||||
| SSKN | STRATA Skin | 0.35 | ||||
| NPCE | Neuropace | 2.62 | ||||
| AXDX | Accelerate Diagnostics | 2.73 | ||||
| AXGN | Axogen | 5.41 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Acutus Stock
If you are still planning to invest in Acutus Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acutus Medical's history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |